Obesity should not be considered a barrier for a patient who needs a shoulder replacement procedure, researchers argued in a ...

“While BMI thresholds have been used to limit access to joint replacement surgery, our findings do not support restricting ...

A poll from the American Gastroenterological Association found that 80% of American adults say gastroenterologists play a ...

Top scientists from have suggested that GLP-1s could have broader effects than just tackling obesity and diabetes.

The worldwide prevalence of high blood pressure in children and adolescents nearly doubled between 2000 and 2020, new ...

Tirzepatide, semaglutide, and liraglutide lead to weight loss in adults with obesity and T1D over 1 year; the greatest weight ...

Researchers have identified a neural biomarker of compulsive food cravings, and showed that it is suppressed by the ...

The Denmark-based company slashed prices for the first two monthly doses of Wegovy and Ozempic for those who pay cash for the ...

Novo Nordisk A/S is undercutting archrival Eli Lilly & Co. on obesity drugs for cash-pay patients, showing its willingness to ...

Discover six obesity deals made so far in 2025, with dealmaking activity in the field being largely dominated by big pharma ...

Eli Lilly & Co. and Novo Nordisk A/S plan to start selling their popular obesity shots to employers through a new approach ...

While heart disease, diabetes and prediabetes are the most common health concerns related to obesity, many other conditions ...